Japan's experience with living-donor kidney transplantation across ABO barriers

Nature Clinical Practice Nephrology

Volumn 4, Issue 12, 2008, Pages 682-692

  Ichimaru, Naotsugu ^a,b   Takahara, Shiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ABO incompatible living donor kidney transplantation; Accommodation; Antigen removal; Desensitization; Splenectomy

Indexed keywords

ANTIBODY; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCRELIZUMAB; OFATUMUMAB; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; AGRANULOCYTOSIS; BLOOD GROUP ABO INCOMPATIBILITY; DESENSITIZATION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; JAPAN; KIDNEY TRANSPLANTATION; LIVING DONOR; OUTCOME ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPLENECTOMY; SURVIVAL RATE;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; DESENSITIZATION, IMMUNOLOGIC; GRAFT REJECTION; HUMANS; JAPAN; KIDNEY TRANSPLANTATION; LIVING DONORS; TREATMENT OUTCOME;

EID: 56749133302     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0967     Document Type: Review

References (58)

1. Japanese Society for Dialysis Therapy, Patient Registration Committee (2008) Changes in number of chronic hemodialysis patients [Japanese]. In An Overview of Regular Dialysis Treatment in Japan as of December 31, 2007 [CDROM]. Tokyo, Japan: Japanese Society for Dialysis Therapy
2. Yuzawa K et al. (2006) Outcome of laparoscopic live donor nephrectomy in 2005: National survey of Japanese transplantation centers. Transplant Proc 38: 3409-3411
3. Japanese Society for Transplantation (online 2007) Organ Transplantation Fact Book [Japanese] [http://www.asas.or.jp/jst/pdf/fct2007.pdf] (accessed 7 August 2008)
4. Ota K et al. (1969) Indication of kidney transplantation and selection of the donor [Japanese]. Surgical diagnosis and treatment 11: 589-595
5. Alexandre GP et al. (1985) Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 17: 138-143
6. Alexandre GP et al. (1987) Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 19: 4538-4542
7. Ota K et al. (1992) Multicentre trial of ABO-incompatible kidney transplantation: Japanese Biosynsorb ABO-incompatible kidney transplant study group. Transpl Int 5 (suppl 1): S40-S43
8. Japanese Society for Clinical Renal Transplantation and Japanese Society for Transplantation (2007) Annual progress report from the Japanese Renal Transplant Registry, 2007: Part III: results from 2006 follow-up survey [Japanese]. Jpn J Transplant 42: 545-557
9. Yoshimura K et al. (2003) Experience with laparoscopic splenectomy for ABO-incompatible living related renal transplantation. J Endourol 17: 751-754
10. Takahashi K and The Japanese ABO-incompatible Transplantation Society (2007) Present status of ABO-incompatible kidney transplantation in Japan [Japanese]. Transplantation Now 20: 552-564
11. Takahashi K (2005) A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 19 (suppl 14): S76-S85
12. Takahashi K (2001) Cases in which hyperacute humoral rejection developed during surgery as a result of transfusion with frozen plasma of the same blood type as the recipient. In ABO Incompatible Kidney Transplantation. Amsterdam, The Netherlands: Elsevier Science BV
13. Takahashi K (2004) Accommodation in ABO-incompatible kidney transplantation: why do kidney grafts survive? Transplant Proc 36: 193S-196S
14. Takahashi K (2001) A case of acute humoral rejection triggered by bacterial infection. In ABO Incompatible Kidney Transplantation. Amsterdam, The Netherlands: Elsevier Science BV
15. Takahashi K (2007) Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 11: 128-141
16. Takahashi K et al. (2004) Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 4: 1089-1096
17. Shimmura H et al. (2000) Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 70: 1331-1335
18. Shimmura H et al. (2005) Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation 80: 985-988
19. Mitsuhata N et al. (2006) Splenectomy and preoperative risks in ABO-incompatible kidney transplants. Transplantation 82: 719-720
20. Tyden G et al. (2006) The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplantation 13: 105-107
21. Montgomery RA et al. (2006) New options for patients with donor incompatibilities. Transplantation 82: 164-165
22. Tyden G et al. (2003) Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 76: 730-731
23. Tyden G et al. (2007) Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 83: 1153-1155
24. Gloor JM et al. (2005) A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 80: 1572-1577
25. Aikawa A et al. (2004) Clinical outcome and accommodation in ABO incompatible kidney transplantation. Clin Transpl 135-142
26. Tanabe K (2007) Double-filtration plasmapheresis. Transplantation 84: S30-S32
27. Wilpert J et al. (2007) On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant 22: 3048-3051
28. Kobayashi T and Saito K (2007) Interinstitutional variation in measurement of anti-blood group A and B antibody. In The New Strategies of ABO Incompatible Transplantation. Tokyo, Japan: Nihon Igakukan
29. Tanabe K (2007) Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey. Transplantation 84 (suppl 12): S13-S16
30. Yung GP et al. (2007) Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation. Transplantation 84: S20-S23
31. Bensinger WI et al. (1981) Immunoadsorption for removal of A and B blood-group antibodies. N Engl J Med 304: 160-162
32. Bannett AD et al. (1987) Immunoadsorption and renal transplant in two patients with a major ABO incompatibility. Transplantation 43: 909-911
33. Norden G et al. (2006) ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 13: 148-153
34. Donauer J et al. (2006) ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Xenotransplantation 13: 108-110
35. Kaplan B et al. (2007) Successful rescue of refractory severe antibody mediated rejection with splenectomy. Transplantation 83: 99-100
36. El-Alfy MS and El-Sayed MH (2004) Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention? Hematol J 5: 77-80
37. Bourgault AM et al. (1979) Severe infection due to Streptococcus pneumoniae in asplenic renal transplant patients. Mayo Clin Proc 54: 123-126
38. Kumar D et al. (2007) Immunogenicity of pneumococcal vaccine in renal transplant recipients - three year follow-up of a randomized trial. Am J Transplant 7: 633-638
39. Hansen K and Singer DB (2001) Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol 4: 105-121
40. Shishido S and Hasegawa A (2005) Current status of ABO-incompatible kidney transplantation in children. Pediatr Transplant 9: 148-154
41. Takahashi K and Saito K (2006) Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation 13: 118-122
42. Saito K et al. (2006) Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplantation 13: 111-117
43. Salama AD and Pusey CD (2006) Drug Insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2: 221-230
44. Sawada T et al. (2002) Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 74: 1207-1210
45. Imamura R et al. (2006) ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report. Xenotransplantation 13: 133-135
46. Sonnenday CJ et al. (2004) Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 4: 1315-1322
47. Tyden G et al. (2005) ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5: 145-148
48. Mitsuhata N et al. (2006) ABO-incompatible renal transplantation without splenectomy between husband and wife among the ever oldest patients. Am J Transplant 6: 3040-3041
49. Vieira CA et al. (2004) Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation 77: 542-548
50. Grim SA et al. (2007) Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant 21: 628-632
51. Chaiwatanatorn K et al. (2003) Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol 121: 913-918
52. Coiffier B et al. (2008) Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study. Blood 111: 1094-1100
53. th quality assessment of cyclosporin blood monitoring by 56 Japanese laboratories. Transplant Proc 30: 1706-1708
54. Matsuda T et al. (2006) The endoscopic surgical skill qualification system in urological laparoscopy: a novel system in Japan. J Urol 176: 2168-2172
55. Gloor JM and Stegall MD (2007) ABO incompatible kidney transplantation. Curr Opin Nephrol Hypertens 16: 529-534
56. Ochiai T et al. (1987) Development of malignancies in Japanese renal transplant recipients. Transplant Proc 19: 2967-2970
57. Imanishi M et al. (1996) Study on the seven cases of malignant tumor after renal transplantation in our institution and statistic data of malignant tumor after renal transplantation in Japan [Japanese]. Jpn J Transplant 31: 100-107
58. Imao T et al. (2007) Risk factors for malignancy in Japanese renal transplant recipients. Cancer 109: 2109-2115